Jane Street
VIR icon

Jane Street’s Vir Biotechnology VIR Stock Holding History

Jane Street’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$995K Buy
111,000
+98,200
+767% +$782K ﹤0.01% 6501
2025
Q4 		$77.2K Buy
+12,800
New +$76.2K ﹤0.01% 10322
2024
Q1 		– Sell
-35,600
Closed -$358K – 10147
2023
Q4 		$358K Buy
35,600
+5,500
+18% +$50.3K ﹤0.01% 7346
2023
Q3 		$282K Sell
30,100
-10,000
-25% -$143K ﹤0.01% 7150
2023
Q2 		$984K Sell
40,100
-8,800
-18% -$221K ﹤0.01% 5212
2023
Q1 		$1.14M Sell
48,900
-14,700
-23% -$376K ﹤0.01% 4773
2022
Q4 		$1.61M Sell
63,600
-26,400
-29% -$647K ﹤0.01% 4199
2022
Q3 		$1.74M Sell
90,000
-74,200
-45% -$1.89M ﹤0.01% 4440
2022
Q2 		$4.18M Buy
164,200
+50,100
+44% +$1.17M ﹤0.01% 2935
2022
Q1 		$2.94M Sell
114,100
-102,600
-47% -$3.04M ﹤0.01% 4009
2021
Q4 		$9.07M Buy
216,700
+143,200
+195% +$5.61M ﹤0.01% 2007
2021
Q3 		$3.2M Buy
73,500
+15,900
+28% +$688K ﹤0.01% 3538
2021
Q2 		$2.72M Sell
57,600
-52,400
-48% -$2.38M ﹤0.01% 3744
2021
Q1 		$5.64M Buy
110,000
+58,600
+114% +$3.16M ﹤0.01% 2240
2020
Q4 		$1.38M Sell
51,400
-8,500
-14% -$276K ﹤0.01% 4139
2020
Q3 		$2.06M Buy
59,900
+41,800
+231% +$1.8M ﹤0.01% 2988
2020
Q2 		$742K Buy
+18,100
New +$608K ﹤0.01% 4501

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Jane Street's VIR Position: Q1 2026 in Review

Jane Street reduced its Vir Biotechnology (VIR) stake by 75% in Q1 2026, selling an estimated $1.58M and leaving 66,344 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #7647.

Jane Street first reported a position in VIR in Q2 2020 and has held it in 22 quarters since. The position peaked at $5.32M in Q4 2021. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Jane Street held 66,344 shares of Vir Biotechnology worth $594K as of Q1 2026.
  • Jane Street sold 197,662 Vir Biotechnology shares in Q1 2026, an estimated $1.58M.
  • Vir Biotechnology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7647 holding.
  • Jane Street first reported a position in Vir Biotechnology in Q2 2020 and has held it in 22 quarters since.
  • Jane Street's Vir Biotechnology position peaked at $5.32M in Q4 2021.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.